Renee Willmon and MG Registry featured in new Rare Disease Article Series

Alira Health’s Senior Director of Evidence and Outcomes Renee Willmon was recently featured in the new Rare Community Profiles series on Patient Worthy®. In the article, “Alira Health and the MGFA Partner to Develop a Myasthenia Gravis Registry,” Renee shares how her professional journey has led her to her current involvement in patient registry development.

Renee Willmon is the Registry Lead on the Alira Health side of the partnership with MGFA, and works with both teams to ensure that MG patients’ experiences are well-represented in the registry and that other stakeholders can access and use the data to improve the development of new treatments, and access to care for MG.

I was really interested in the vision of empowering patients to take a more active role in shared decision-making, the health data they’re generating, and how they can use technology to democratize clinical research."
Renee Willmon Senior Director of Evidence and Outcomes, Alira Health

Patient Worthy® is an online publication that provides relevant information to rare disease patients, caregivers and advocates alike. Rare Community Profiles is a new Patient Worthy article series of long-form interviews featuring various stakeholders in the rare disease community, such as patients, their families, advocates, scientists, and more.

Related news

News May 22, 2023
Alira Health Joins France Biotech as an Expert Partner
We are pleased to announce that Alira Health has joined France Biotech, an independent association that brings together healthcare innovation entrepreneurs and their expert partners.
Biotech Clinical Trials France Patient Engagement
Multimedia May 17, 2023
Webinar: How to Increase Patient Engagement in Your Clinical Trials
Engaging with patients, including their caregivers and advocates, is crucial during the planning and execution of clinical trials.
Clinical Trials Patient Engagement
Events May 16, 2023
PSI 2023 Conference
We're excited to talk orphan drugs and rare diseases at the World Orphan Drug Congress in Washington, D.C.
Orphan Drug Pharma Rare Disease UK
Events May 15, 2023
World Orphan Drug Congress USA
We're excited to talk orphan drugs and rare diseases at the World Orphan Drug Congress in Washington, D.C.
Orphan Drug Pharma Rare Disease
Blog May 4, 2023
How to Leverage Real-World Evidence to Achieve Orphan Drug Designation
Obtaining an orphan drug designation (ODD) is challenging and may require sponsors to leverage real-world evidence (RWE). Read the article to learn what ODD is, why it matters, and how RWE can help.
Orphan Drug Rare Disease Real-World Evidence (RWE)
Events April 28, 2023
EWMA 2023
We are pleased to announce that we will join as delegates the 33rd Conference of the EWMA. This year’s theme is “Wound Care - from art to science”, and as always, the conference(...)
Clinical Trials Product Development Wound Healing
Events April 24, 2023
XII Jornada Anual Programa Hospital Clínic de Enfermedades Minoritarias
We are thrilled to be sponsors of XII Jornada Anual Programa Hospital Clínic de Enfermedades Minoritarias organized by the Hospital Clínic of Barcelona.
Rare Disease
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.